AKT1 and breast carcinoma: In addition, high doses of AhR ligand aminoflavone (AF) acts as an AhR antagonist, inhibiting Src-Akt signaling and suppressing α6-integrin expression to attenuate tamoxifen-resistance in MCF-7 breast cancer cells [119].